Skip to main content

Advertisement

Log in

In-office Discussions of Migraine: Results from the American Migraine Communication Study

  • Original Article
  • Published:
Journal of General Internal Medicine Aims and scope Submit manuscript

Abstract

Background

Research indicates that successful migraine assessment and treatment depends on information obtained during patient and healthcare professional (HCP) discussions. However, no studies outline how migraine is actually discussed during clinical encounters.

Objective

Record naturally occurring HCP–migraineur interactions, analyzing frequency and impairment assessment, and preventive treatment discussions.

Design

HCPs seeing high volumes of migraineurs were recruited for a communication study. Patients likely to discuss migraine were recruited immediately before their normally scheduled appointment and, once consented, were audio- and video-recorded without a researcher present. Separate post-visit interviews were conducted with patients and HCPs. All interactions were transcribed.

Participants

Sixty patients (83% female; mean age 41.7) were analyzed. Patients were diagnosed with migraine 14 years and experienced 5 per month, on average.

Approach

Transcripts were analyzed using sociolinguistic techniques such as number and type of questions asked and post-visit alignment on migraine frequency and impairment. American Migraine Prevalence and Prevention Study guidelines were utilized.

Results

Ninety-one percent of HCP-initiated, migraine-specific questions were closed-ended/short answer; assessments focused on frequency and did not focus on attention on impairment. Open-ended questions in patient post-visit interviews yielded robust impairment-related information. Post-visit, 55% of HCP–patient pairs were misaligned regarding frequency; 51% on impairment. Of the 20 (33%) patients who were preventive medication candidates, 80% did not receive it and 50% of their visits lacked discussion of prevention.

Conclusions

Sociolinguistic analysis revealed that HCPs often used narrowly focused, closed-ended questions and were often unaware of how migraine affected patients’ lives as a result. It is recommended that HCPs assess impairment using open-ended questions in combination with the ask-tell-ask technique.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Figure 1

Similar content being viewed by others

References

  1. Lipton RB, Diamond S, Reed M, Diamond ML, Stewart WF. Migraine diagnosis and treatment: results from the American Migraine Study II. Headache. 2001;4(17)638–45.

    Article  PubMed  CAS  Google Scholar 

  2. Lipton RB, Stewart RF. Acute migraine therapy: do doctors understand what patients with migraine want from therapy? Headache. 1999;39(Suppl 2)S20–6.

    Article  Google Scholar 

  3. Lipton RB, Scher AI, Kolodner K, Liberman J, Steiner TJ, Stewart WF. Migraine in the United States: epidemiology and patterns of health care use. Neurology. 2002;58(6)885–94.

    PubMed  CAS  Google Scholar 

  4. Barrier PA, Li JT, Jensen NM. Two words to improve physician–patient communication: what else? Mayo Clin Proc. 2003;78(2)211–4.

    PubMed  Google Scholar 

  5. Mueller PS, Barrier PA, Call TG, Duncan AK, Hurley DL, Multari A, Rabatin JT, Li JT. Views of new internal medicine faculty of their preparedness and competence in physician–patient communication. BMC Med Educ. 2006;6:30.

    Article  PubMed  Google Scholar 

  6. Silberstein S. Practice parameters: evidence-based guidelines for migraine headache (an evidence-based review): report of the quality standards subcommittee of the American Academy of Neurology. Neurology. 2000;55:754–62.

    PubMed  CAS  Google Scholar 

  7. Taylor F, Hutchinson S, Cady R, Harris L, Graff-Radford S. Diagnosis and management of migraine. Strategies to improve headache diagnosis and treatment in family practice. J Fam Pract. 2004;Suppl:S3–4.

    PubMed  Google Scholar 

  8. Cottrell CK, Drew JB, Waller SE, Holroyd KA, Brose JA, O’Donnell FJ. Perceptions and needs of patients with migraines: a focus group study. J Fam Pract. 2002;5(12)142–7.

    PubMed  Google Scholar 

  9. Dodick D. Patient perceptions and treatment preferences in migraine management. CNS Drugs. 2002;16(Suppl 1)19–24.

    Article  PubMed  Google Scholar 

  10. Levin M. Migraine headache: accurate diagnosis, targeted treatment. Adv Stud Med. 2004;44208–9.

    Google Scholar 

  11. Lipton RB, Bigal ME, Stewart WF. Clinical trials of acute treatments for migraine including multiple attack studies of pain, disability, and health-related quality of life. Neurology. 2005;12Suppl 4S50–8.

    Google Scholar 

  12. Lipton RB, Bigal ME, Diamond M, Freitag F, Reed ML, Stewart WF. Migraine prevalence, disease burden and need for preventive therapy. Neurology. 2007;68(5)343–9.

    Article  PubMed  CAS  Google Scholar 

  13. Roter D, Hall J. Doctors Talking with Patients/Patients Talking with Doctors: Improving Communication in Medical Visits. Westport: Auburn House; 1992.

    Google Scholar 

  14. Becker WJ. Communication with the migraine patient. Can J Neurol Sci. 2002;29(Suppl 2)1–2.

    Google Scholar 

  15. Edmeads J. Communication issues in migraine diagnosis. Can J Neurol Sci. 2002;29(Suppl 2):S8–10.

    PubMed  Google Scholar 

  16. Franks P, Jerant AF, Fiscella K, Shields CG, Tancredi DJ, Epstein RM. Studying physician effects on patient outcomes: physician interactional style and performance on quality of care indicators. Soc Sci Med. 2006;6(2):2422–32.

    Article  PubMed  Google Scholar 

  17. Robinson G. Effective doctor patient communication: building bridges and bridging barriers. Can J Neurol Sci. 2002;29(Suppl 2):S30–2.

    PubMed  Google Scholar 

  18. Sheftell FD. Communicating the right therapy for the right patient at the right time: acute therapy. Can J Neurol Sci. 2002;29(Suppl 2):S33–9.

    PubMed  Google Scholar 

  19. Baos V, Ester F, Castellanos A, Nocea G, Caloto MT, Gerth WC. Use of a structured migraine diary improves patient and physician communication about migraine disability and treatment outcomes. Int J Clin Pract. 2005;59(3):281–6.

    Article  PubMed  CAS  Google Scholar 

  20. Cady RK, Borchert LD, Spalding W, Hart CC, Sheftell FD. Simple and efficient recognition of migraine with 3-question headache screen. Headache. 2004;44:323–27.

    Article  PubMed  Google Scholar 

  21. Lipton RB, Bigal ME, Amatniek JC, Stewart WF. Tools for diagnosing migraine and measuring its severity. Headache. 2004;44:387–98.

    Article  PubMed  Google Scholar 

  22. Lipton RB, Dodick DD, Sadovsky R, Kolodner K, Endicott J, Hettiarachchi J, et al.. A self-administered screener for migraine in primary care. The ID Migraineä validation study. Neurology. 2003;61:375–82.

    PubMed  CAS  Google Scholar 

  23. Marcus DA, Kapelewski C, Jacob RG, Rudy TE, Furman JM. Validation of a brief nurse-administered migraine assessment tool. Headache. 2004;44:328–32.

    Article  PubMed  Google Scholar 

  24. Stewart WF, Lipton RB. Need for care and perceptions of MIDAS among headache sufferers study. CNS Drugs. 2002;16(Suppl 1):S5–11.

    Article  Google Scholar 

  25. Holmes WF, MacGregor EA, Sawyer JPC, Lipton RB. Information about migraine disability influences physicians’ perception of illness severity and treatment needs. Headache. 2001;41(4):343–50.

    Article  PubMed  CAS  Google Scholar 

  26. Gumperz JJ. Discourse Strategies. Cambridge: Cambridge University Press; 1982.

    Google Scholar 

  27. Gumperz JJ. On Interactional Sociolinguistic Method. In: Sarangi S, Roberts C, eds. Talk, work and institutional order. Discourse in medical, mediation and management settings. Berlin: Mouton de Gruyter; 1999:453–71.

    Google Scholar 

  28. Hamilton HE. Symptoms and signs in particular. The influence of the medical condition on the shape of physician–patient talk. Commun Med. 2004;1(1):59–70.

    Article  PubMed  Google Scholar 

  29. Hamilton HE, Nelson M, Martin P, Cotler SJ. Provider–patient in-office discussions of response to hepatitis C antiviral therapy and impact on patient comprehension. Clin Gastroenterol Hepatol. 2006;44507–13.

    Article  PubMed  Google Scholar 

  30. Aranguri C, Davidson B, Ramirez R. Patterns of communication through interpreters: a detailed sociolinguistic analysis. J Gen Intern Med. 2006;21:623–29.

    Article  PubMed  Google Scholar 

  31. Davidson B, Vogel V, Wickerham L. Oncologist–patient discussion of adjuvant hormonal therapy in breast cancer: results of a linguistic study focusing on adherence and persistence to therapy. J Support Oncol. 2007;5:36–40.

    PubMed  Google Scholar 

  32. Davidson B, Blum D, Cella D, Hamilton H, Nail L, Waltzman R. Communicating about chemotherapy-induced anemia. J Support Oncol. 2007;5:36–40. 46.

    PubMed  Google Scholar 

  33. Blumenfeld A, Tischio M. Center of excellence for headache care: group model at Kaiser Permanente. Headache. 2003;43(5):431–40.

    Article  PubMed  Google Scholar 

  34. Speer S, Hutchby I. From ethics to analytics: aspects of participants’ orientations to the presence and relevance of recording devices. Sociology. 2003;37(2):315–37.

    Article  Google Scholar 

  35. Dyche L, Swiderski D. The effects of physician solicitation approaches on ability to identify patient concerns. J Gen Intern Med. 2005;20(3):267–70.

    Article  PubMed  Google Scholar 

  36. Frankel R, Altschuler A, George S, Kinsman J, Jimison H, Robertson NR, Hsu J. Effects of exam-room computing on clinician–patient communication: a longitudinal qualitative study. J Gen Intern Med. 2005;20(8):677–82.

    Article  PubMed  Google Scholar 

  37. Suchman AL, Markakis K, Beckman HB, Frankel R. A model of empathic communication in the medical interview. JAMA. 1997;277(8):678–82.

    Article  PubMed  CAS  Google Scholar 

  38. Lipton RB, Diamond M, Freitag D, Bigal M, Stewart WF, Reed ML. Migraine prevention patterns in a community sample: results from the American Migraine Prevalence and Prevention (AMPP) Study. Poster presented at the American Headache Society’s 47th Annual Scientific Meeting. June 2005. Philadelphia, PA.

  39. Berry DL, Wilkie DJ, Thomas CR, Fortner P. Clinicians communicating with patients experiencing cancer pain. Cancer Invest. 2003;21(3):374–81.

    Article  PubMed  Google Scholar 

  40. Braddock CH, Synder L. The doctor will see you shortly. The ethical significance of time for the patient–physician relationship. J Gen Intern Med. 2005;20(11):1057–62.

    Article  PubMed  Google Scholar 

  41. Dowson AJ. Assessing the impact of migraine. Curr Med Res Opin. 2001;17(4):298–309.

    Article  PubMed  CAS  Google Scholar 

  42. Dueland AN, Leira R, Cabelli S. The impact of migraine on psychological well-being of young women and their communication with physicians about migraine. Curr Med Res Opin. 2005;21(8):1297–305.

    Article  PubMed  Google Scholar 

  43. Lipton RB, Bigal ME, Rush SR, Yenkosky JP, Liberman JN, Bartleson JD, et al.. Migraine practice patterns among neurologists. Neurology. 2004;62:1926–31.

    PubMed  CAS  Google Scholar 

  44. Robinson JD, Heritage J. Physicians’ opening questions and patients’ satisfaction. Patient Educ Couns. 2006;60(3):279–85.

    Article  PubMed  Google Scholar 

  45. Greer J, Halgin R. Predictors of physician–patient agreement on symptom etiology in primary care. Psychosom Med. 2006;68(2):277–82.

    Article  PubMed  Google Scholar 

  46. Hagihara A, Odamaki M, Nobutomo K, Tarumi K. Physician and patient perceptions of the physician explanations in medical encounters. J Health Psychol. 2006;11(1):91–105.

    Article  PubMed  Google Scholar 

  47. Abdel-Tawab N, Roter D. The relevance of client-centered communication to family planning settings in developing countries: lessons from the Egyptian experience. Soc Sci Med. 2002;54(9):1357–68.

    Article  PubMed  Google Scholar 

  48. Headache Study Group. Predictors of outcome in headache patients presenting to family physicians—a one year prospective study. Headache. 1986;26:285–94.

    Article  Google Scholar 

  49. Hahn SR. Communication in the Care of the Headache Patient. In: Silberstein S, Lipton RB, Dodick D, eds. Wolff's Headache and Other Head Pain. Eighth ed. New York: Oxford University Press; 2007:805–24.

    Google Scholar 

  50. Frymoyer JW, Frymoyer NP. Physician–patient communication: a lost art? J Am Acad Orthop Surg. 2002;10(2):95–105.

    PubMed  Google Scholar 

  51. Ishikawa H, Takayama T, Yamazaki Y, Seki Y, Katsumata N. Physician–patient communication and patient satisfaction in Japanese cancer consultations. Soc Sci Med. 2002;55(2):301–11.

    Article  PubMed  Google Scholar 

  52. Martin LR, Jahng KH, Golin CE, DiMatteo MR. Physician facilitation of patient involvement in care: correspondence between patient and observer reports. Behav Med. 2003;28(4):159–64.

    Article  PubMed  Google Scholar 

  53. Roter DL, Larson S, Shinitzky H, Chernoff R, Serwint JR, Adamo G, Wissow L. Use of an innovative video feedback technique to enhance communication skills training. Med Educ. 2004;38(2):145–47.

    Article  PubMed  Google Scholar 

  54. Back AL, Arnold RM, Baile WF, Tulsky JA, Fryer-Edwards K. Approaching difficult communication tasks in oncology. CA Cancer J Clin. 2005;55(3):164–77.

    Article  PubMed  Google Scholar 

  55. Boyle D, Dwinnell B, Platt F. Invite, listen, and summarize: a patient-centered communication technique. Acad Med. 2005;80(1):29–32.

    Article  PubMed  Google Scholar 

  56. Lipton RB, Stewart WF, Simon D. Medical consultation for migraine: results from the American Migraine Study. Headache. 1998;38:87–96.

    Article  PubMed  CAS  Google Scholar 

  57. Rao JK, Anderson LA, Inui TS, Frankel RM. Communication interventions make a difference in conversations between physicians and patients: a systematic review of the evidence. Medical Care. 2007;45(4):340–9.

    Article  PubMed  Google Scholar 

Download references

Acknowledgements

The authors wish to thank Ortho-McNeil Neurologics and Corey Eagan of MBS/Vox.

Conflict of interest summary

Dr. Lipton has received grants from Allergan, Advanced Bionics Corporation, GlaxoSmithKline, Merck & Co., Inc., Neuralieve, Ortho-McNeil, Pfizer, Proethics Ltd., and St. Jude Children’s Research Hospital. He has consulted for Allergan, Ortho-McNeil, and Pfizer.

Dr. Hahn has received honoraria from GlaxoSmithKline, Eli Lilly and Company, Ortho-McNeil, and Pfizer. He has consulted with GlaxoSmithKline, Eli Lilly and Company, Ortho-McNeil, and Pfizer.

Dr. Cady is the owner of Banyan Group, Inc., a medical clinic, clinical research facility, and meeting planning division that conducts medical education. Banyan Group has received grants from Abbott Laboratories, Advanced Bionics Corporation, Alizyme, Allergan, Alexza Pharmaceuticals, Aradgim Corporation, CAPNIA, Incorporated, Cipher Pharmaceuticals, Inc., Eisai, Inc., Endo Pharmaceuticals, GelStat Corp., GlaxoSmithKline, Jazz Pharmaceuticals, Johnson & Johnson, MAP Pharmaceuticals, Matrixx Initiatives, Inc., Merck & Co., Neuralieve, Novartis, Ortho-McNeil, Pfizer, Pozen Pharmaceutical Development Company, SCHWARZ Pharma AG, Torrey Pines, and Vernalis. He has received honoraria from ABT Associates, Allergan, Aradgim Corp., Atrix, Capnia, Endo, GlaxoSmithKline, Jazz Pharmaceuticals, Johnson & Johnson, MedPointe Pharmaceuticals, Merck & Co., Inc., and Winston Laboratories, Inc. He has consulted for ABT Associates, Allergan, Aradgim Corp., Atrix, CAPNIA Incorporated, Endo Pharmaceuticals, GlaxoSmithKline, Jazz Pharmaceuticals, Johnson & Johnson, MedPointe Pharmaceuticals, Merck & Co., Inc., and Winston Laboratories, Inc.

Dr. Brandes has received clinical or educational support from Advanced Bionics Corporation, Allergan, AstraZeneca, Bristol-Myers Squibb, Elan Pharmaceuticals, Endo Pharmaceuticals, GlaxoSmithKline, Johnson & Johnson, Merck & Co., Inc., Novartis, Ortho-McNeil, Pfizer, Pozen Pharmaceutical Development Company, Sanofi-Aventis, UCB, Vernalis, and Winston Laboratories, Inc. She is on the Speakers’ Bureau/Advisory Board for Allergan, AstraZeneca, Endo Pharmaceuticals, GlaxoSmithKline, Merck, Ortho-McNeil, and Pfizer.

Ms. Simons has no conflicts to declare.

Dr. Bain has no conflicts to declare.

Ms. Nelson has no conflicts to declare.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Richard B. Lipton MD.

Additional information

Study design and subsequent publication were a joint effort by MBS/Vox, academic co-authors, and Ortho-McNeil Neurologics. All data collection and analysis was conducted by MBS/Vox. Funding was provided by Ortho-McNeil Neurologics.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Lipton, R.B., Hahn, S.R., Cady, R.K. et al. In-office Discussions of Migraine: Results from the American Migraine Communication Study. J GEN INTERN MED 23, 1145–1151 (2008). https://doi.org/10.1007/s11606-008-0591-3

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11606-008-0591-3

Key words

Navigation